JPMorgan Chase & Co. Analysts Give Siemens Healthineers (ETR:SHL) a €35.80 Price Target

JPMorgan Chase & Co. set a €35.80 ($41.63) price objective on Siemens Healthineers (ETR:SHL) in a research note published on Tuesday morning, Borsen Zeitung reports. The firm currently has a sell rating on the stock.

Several other brokerages have also recently issued reports on SHL. Goldman Sachs Group set a €38.00 ($44.19) price objective on Siemens Healthineers and gave the company a neutral rating in a research note on Monday, November 11th. Deutsche Bank set a €40.00 ($46.51) price objective on Siemens Healthineers and gave the company a neutral rating in a research note on Tuesday, November 5th. Morgan Stanley set a €39.00 ($45.35) price objective on Siemens Healthineers and gave the company a sell rating in a research note on Friday, December 6th. Commerzbank set a €45.00 ($52.33) price objective on Siemens Healthineers and gave the company a buy rating in a research note on Monday, November 4th. Finally, Credit Suisse Group set a €37.00 ($43.02) price objective on Siemens Healthineers and gave the company a neutral rating in a research note on Friday, November 8th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have given a buy rating to the company’s stock. The company has an average rating of Hold and a consensus price target of €39.61 ($46.06).

Shares of ETR SHL opened at €42.18 ($49.05) on Tuesday. The stock has a market cap of $42.18 billion and a P/E ratio of 26.90. The company has a current ratio of 1.39, a quick ratio of 1.00 and a debt-to-equity ratio of 46.32. Siemens Healthineers has a 12-month low of €33.05 ($38.42) and a 12-month high of €44.80 ($52.09). The business’s fifty day simple moving average is €42.11 and its 200-day simple moving average is €37.71.

About Siemens Healthineers

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

Recommended Story: What Does a Sell-Side Analyst Rating Mean?

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.